Vifor Pharma and Angion Report Topline Results From Phase-II GUARD Trial of ANG-3777 in Cardiac Surgery Associated Acute Kidney Injury

ST. GALLEN, Switzerland & UNIONDALE, N.Y. — Regulatory News: Read More